Globus Medical, Inc. GMED
Nov 4, 2026, 11:47 AM EST
- YTD
- -1.12%
- 1 year
- +40.01%
- Market cap
- 11.60B
- Revenue (ttm)
- 3.14B
- Profit margin
- 17.03%
- EPS (ttm)
- 3.90
- Shares out
- 111.83M
- P/E ratio
- 22.15
- Forward P/E
- 14.76
- YTD return
- -1.12%
- 1-year return
- +40.01%
- Volume
- 662.58K
- Avg volume
- 1.43M
- Open
- 82.78
- Previous close
- 79.58
- Day's range
- 80.91 – 86.37
- 52-week range
- 60.26 – 101.40
- Beta
- 0.95
- Analysts
- Buy
- Price target
- 100.92 (+16.9%)
- Earnings date
- Nov 5, 2026
2Y +11.23 (+15.03%)
Key statistics
- Enterprise value
- 10.19B
- PEG ratio
- 1.49
- Price / sales
- 3.40
- Price / book
- 2.24
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 5.90%
- Free cash flow
- 554.19M
- Total cash
- 595.14M
- Total debt
- 111.91M
- Return on equity
- 11.81%
- Short % of float
- 7.38%
- 50-day average
- 77.47
- 200-day average
- 83.42
Analyst view
Consensus: buy
- Target (low)
- 84.00
- Target (mean)
- 100.92
- Target (high)
- 125.00
- Strong buy3
- Buy7
- Hold4
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 1.20.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 1.20 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 1.10 | 1.34 | +0.24 | +21.82% |
| May 7, 2026 | Mar 31, 2026 | 0.92 | 1.12 | +0.20 | +21.74% |
| Feb 24, 2026 | Dec 31, 2025 | 1.06 | 1.28 | +0.22 | +20.75% |
| Nov 6, 2025 | Sep 30, 2025 | 0.781 | 1.18 | +0.40 | +51.09% |
| Aug 7, 2025 | Jun 30, 2025 | 0.76 | 0.86 | +0.10 | +13.16% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 2026 | RBC Capital | main | Outperform | Outperform |
| Aug 7, 2026 | Wells Fargo | main | Overweight | Overweight |
| Jul 28, 2026 | UBS | init | — | Neutral |
| Jul 16, 2026 | Truist Securities | main | Buy | Buy |
| Jul 13, 2026 | RBC Capital | main | Outperform | Outperform |
| Jul 9, 2026 | BMO Capital | init | — | Outperform |
About Globus Medical, Inc.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- globusmedical.com
News
Globus Medical Acquires Synaptive Medical; Financial Terms Not Disclosed
Globus Medical: The Shrinking Robot Line Hides A Growing Annuity
GMED vs. AXGN: Which Stock Should Value Investors Buy Now?
Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
2 Healthcare Technology Stocks for a Digital Health Boom
Gibbs Wealth Management Purchases 7,829 Shares of Globus Medical, Inc. $GMED
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm
Globus Medical (GMED) is a Top-Ranked Value Stock: Should You Buy?
GMED or AXGN: Which Is the Better Value Stock Right Now?
Your note
Sign in to keep a note on GMED — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DAVIDAR DAVID D | Director | Stock Gift | Jul 26, 2026 | 673,642 |
| KLINE KYLE | Chief Financial Officer | Sale | Jan 7, 2026 | 0 |
| LEMAITRE DANIEL | Director | Sale | Nov 21, 2024 | 0 |
| NORWALK LESLIE V | Director | Sale | Jan 7, 2026 | 10,419 |
| PAUL DAVID C | Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security | Dec 7, 2025 | 60,417 |
| PFEIL KEITH W. | Chief Operating Officer | Sale | Jan 9, 2025 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.05% | 10,806,724 | 859.89M | Jun 29, 2026 |
| Jupiter Topco LLC | 6.11% | 8,200,423 | 652.51M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 3.80% | 5,107,532 | 406.41M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 3.72% | 4,994,385 | 397.40M | Jun 29, 2026 |
| Invesco Ltd. | 3.21% | 4,309,771 | 342.93M | Jun 29, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 3.19% | 4,279,730 | 340.54M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 2.97% | 3,983,485 | 316.97M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.68% | 3,595,564 | 286.10M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.93% | 2,597,815 | 206.71M | Jun 29, 2026 |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 1.64% | 2,207,141 | 175.62M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.11% | 1,496,500 | 119.08M | Jun 29, 2026 |
| J.P. Morgan Fleming Mutual Fd. Group, Inc.-JPMorgan Mid Cap Value Fd. | 1.10% | 1,475,978 | 117.44M | Jun 29, 2026 |
